• No.3 Shuiyuan West Road, Miyun District
  • Beijing, 101509
  • చైనా
  • టెల్:010-62622266
  • ఫ్యాక్స్:010-82626933
  • Url:

Glimepiride Tablets

ఫార్మాస్యూటికల్

అభ్యర్థనపై

కొత్త

అందుబాటులో లేదు

అందుబాటులో లేదు

విచారించు

ఉత్పత్తి వివరణ

Glimepiride 1 Tablet is a sulfonylurea hypoglycemic drug that can be used in combination with insulin. In 2001, glimepiride 2 tablet (Dibei), as the first hypoglycemic product of Beilu Pharma, was first listed in China and belongs to the second class of national new drugs.

Product name: Glimepiride Tablets

Specifications: glimepiride 1 mg×30 tablets;glimepiride 2 mg×15 tablets;glimepiride 2mg×30 tablets

Characteristics: White tablet

Indications :

As one of the oral antidiabetic drugs produced by Beilu Pharma, our glimepiride tablets are only suitable for type 2 diabetes that cannot fully control blood sugar through diet control, exercise therapy and weight loss.

Glimepiride tablets are not suitable for type 1 diabetes (for example, the treatment of diabetic patients with a history of ketoacidosis), diabetic ketoacidosis or Treatment of pre-diabetic coma or coma.

Usage and Dosage: Please refer to the package insert

Adverse reactions, Contraindications, Precautions: Please refer to the package insert.

Storage: Shade, seal, and keep in a dry place.

Packaging: Aluminum plastic packaging, 15 pillsate, 1 plate/box; 15 pillsate, 2 plates/box.

Shelf life: 24 months

Advantages of Glimepiride Tablets

Double effect directly hit the hypoglycemic core

Double effect: Glimepiride tablets can promote insulin secretion and improve insulin resistance. At the same time, it can improve the two major pathophysiological abnormalities of insulin secretion and insulin resistance in patients with type 2 diabetes.

Efficiently reduce postprandial blood glucose, fasting blood glucose and glycosylated haemoglobin

Glimepiride 2 mg oral tablet monotherapy can comprehensively reduce FPG PPG and HbA1c in newly diagnosed T2DM patients

Combination therapy, such as combined metformin, acarbose, etc., has a more significant overall hypoglycemic effect

Less hypoglycemia, less weight impact, high safety

Short-term treatment, the risk of glimepiride hypoglycemia is only 1/3 of that of Glibenclamide

Long-term treatment, the risk of glimepiride hypoglycemia is only 1/7of that of Glibenclamide

Glimepiride has a small impact on the weight of T2DM patients

Once a day to improve patient compliance

If the patient's compliance is poor, Glimepiride tablets should be selected, once a day.

Beijing pharmaceuticals is a professional contrast media manufacturer, we provide glimepiride 1mg tablets, glimepiride tab 1mg, glimepiride package insert, mri contrast medium and etc. Want to know glimepiride 2mg tablets used for or side effects of glimepiride 1mg tablet? Please contact us.